Analysts Set Pediatrix Medical Group, Inc. (NYSE:MD) PT at $17.08

Pediatrix Medical Group, Inc. (NYSE:MD - Get Free Report) has earned an average rating of "Hold" from the six analysts that are presently covering the firm, MarketBeat reports. Four research analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12-month price objective among analysts that have covered the stock in the last year is $17.08.

Several equities research analysts recently weighed in on the stock. Mizuho increased their price objective on shares of Pediatrix Medical Group from $13.00 to $15.00 and gave the stock a "neutral" rating in a research note on Tuesday, November 19th. UBS Group raised their price target on Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a "neutral" rating in a report on Friday, February 21st. Truist Financial upped their price objective on Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a "hold" rating in a research note on Friday, February 21st. Macquarie assumed coverage on Pediatrix Medical Group in a research note on Monday, December 16th. They issued an "outperform" rating and a $18.00 target price on the stock. Finally, StockNews.com upgraded shares of Pediatrix Medical Group from a "hold" rating to a "buy" rating in a research report on Wednesday, January 22nd.

Remove Ads

Institutional Investors Weigh In On Pediatrix Medical Group

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. California State Teachers Retirement System increased its stake in shares of Pediatrix Medical Group by 0.9% in the fourth quarter. California State Teachers Retirement System now owns 80,327 shares of the company's stock worth $1,054,000 after acquiring an additional 752 shares during the last quarter. Mackenzie Financial Corp acquired a new position in Pediatrix Medical Group in the 4th quarter worth about $276,000. PharVision Advisers LLC purchased a new stake in shares of Pediatrix Medical Group during the 4th quarter worth about $245,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of Pediatrix Medical Group by 7.8% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 256,335 shares of the company's stock valued at $3,363,000 after buying an additional 18,627 shares during the last quarter. Finally, Voloridge Investment Management LLC bought a new stake in shares of Pediatrix Medical Group in the 4th quarter valued at approximately $396,000. Institutional investors own 97.71% of the company's stock.

Pediatrix Medical Group Stock Up 1.1 %

Shares of MD stock traded up $0.15 on Friday, hitting $14.23. The stock had a trading volume of 214,432 shares, compared to its average volume of 598,760. The stock's 50 day moving average is $14.22 and its 200-day moving average is $13.48. The firm has a market capitalization of $1.22 billion, a price-to-earnings ratio of -11.86, a P/E/G ratio of 1.74 and a beta of 1.49. Pediatrix Medical Group has a 52-week low of $6.62 and a 52-week high of $17.67. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.42 and a current ratio of 1.60.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its quarterly earnings data on Thursday, February 20th. The company reported $0.49 earnings per share for the quarter, beating analysts' consensus estimates of $0.37 by $0.12. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. The company had revenue of $502.36 million during the quarter, compared to analysts' expectations of $486.22 million. As a group, research analysts expect that Pediatrix Medical Group will post 1.38 earnings per share for the current year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.